Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter Complement C4d Antikörper

Der Kaninchen Monoklonal anti-Complement C4d Antikörper wird verwendet zum Nachweis von Complement C4d in Proben von Human. Er wurde validiert für ELISA, IHC und WB.
Produktnummer ABIN7863829
639,45 €
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 6 bis 10 Werktagen

Kurzübersicht für Rekombinanter Complement C4d Antikörper (ABIN7863829)

Target

Complement C4d (C4d) (Complement Component C4d (C4d))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 39
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 29
  • 12
Kaninchen

Klonalität

  • 33
  • 8
Monoklonal

Konjugat

  • 23
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Dieser Complement C4d Antikörper ist unkonjugiert

Applikation

  • 22
  • 21
  • 15
  • 14
  • 12
  • 10
  • 9
  • 7
  • 4
  • 4
  • 3
  • 1
  • 1
  • 1
  • 1
ELISA, Immunohistochemistry (IHC), Western Blotting (WB)

Klon

C4D-9213R
  • Verwendungszweck

    Recombinant Complement 4d (C4d) (Acute Humoral Rejection Marker) Antibody

    Spezifität

    This MAb is specific to Complement 4d (C4d) and reacts with the secreted as well as cell-bound C4d.C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of Abs to specific target molecules. Following activation and degradation of the C4 Molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product Complement 4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. It has been shown to be a significant predictor of transplant kidney graft survival. Anti-C4d, combined with anti-C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

    Aufreinigung

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Recombinant full-length human Complement 4d protein

    Isotyp

    IgG, kappa
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C

    Informationen zur Lagerung

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
  • Target

    Complement C4d (C4d) (Complement Component C4d (C4d))

    Andere Bezeichnung

    Complement 4d

    Hintergrund

    Acidic Complement C4, Basic C4, C4-1, C4a Anaphylatoxin, C4A, C4A2, C4A3, C4A4, C4A6, C4b, C4B1, C4B12, C4d fragment, C4F, C4S, Complement C4 Gamma Chain, Complement Component 4A, Complement Component 4B

    Rejected Renal Transplant Tissue

    Molekulargewicht

    192kDa (predicted)

    Gen-ID

    720, 721

    UniProt

    P0C0L4, P0C0L5
Sie sind hier:
Chat with us!